Showing results (31-40 of 81) with videos related to

Sort By:
Pageof 9
Reproductive Medicine and Biology|April 28, 2018
Anti-Mϋllerian hormone and 3D-power Doppler histogram: markers of ovarian function with in vitro fertilization treatmentMasatoshi Murai, Eriko Takatori, Hideo Omi, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 11, 2015
Fibroblast growth factor receptor 2 is associated with poor overall survival in clear cell carcinoma of the ovary and may be a novel therapeutic approachHiroaki Itamochi, Nao Oumi, Tetsuro Oishi, et al.
Asian Journal of Endoscopic Surgery|January 9, 2026
Safe Trocar Placement by Transvaginal Endoscopic Insertion in Robot-Assisted Surgery for Endometrial Cancer With Umbilical Incisional Hernia and Prior Mesh Repair: Two Case ReportsTakayuki Nagasawa, Nanako Jonai, Minami Oshikiri, et al.
International Journal of Clinical Oncology|July 6, 2016
Neoadjuvant chemotherapy with docetaxel and carboplatin followed by radical hysterectomy for stage IB2, IIA2, and IIB patients with non-squamous cell carcinoma of the uterine cervixMuneaki Shimada, Shoji Nagao, Keiichi Fujiwara, et al.
BMC Cancer|August 2, 2018
An open-label, randomized, phase II trial evaluating the efficacy and safety of standard of care with or without bevacizumab in platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer patients previously treated with bevacizumab for front-line or platinum-sensitive ovarian cancer: rationale, design, and methods of the Japanese Gynecologic Oncology Group study JGOG3023Tadahiro Shoji, Shinichi Komiyama, Junzo Kigawa, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 1, 2014
Pilot study of intraperitoneal administration of triamcinolone acetonide for cancerous ascites in patients with end-stage gynecological cancerTadahiro Shoji, Eriko Takatori, Yuki Miura, et al.
International Journal of Clinical Oncology|January 4, 2025
Cytokine dynamics and quality of life: unraveling the impact of cell-free and concentrated ascites reinfusion therapy in ovarian cancer patientsRikako Ito, Masahiro Kagabu, Sho Sato, et al.
Cancers|December 10, 2021
Novel Therapeutic Strategies for Refractory Ovarian Cancers: Clear Cell and Mucinous CarcinomasTadahiro Shoji, Shunsuke Tatsuki, Marina Abe, et al.
Oncotargets and Therapy|October 4, 2016
A retrospective study of neoadjuvant chemotherapy plus radical hysterectomy versus radical hysterectomy alone in patients with stage II cervical squamous cell carcinoma presenting as a bulky massEriko Takatori, Tadahiro Shoji, Anna Takada, et al.
International Journal of Clinical Oncology|May 15, 2014
Analysis of prognostic factors for patients with bulky squamous cell carcinoma of the uterine cervix who underwent neoadjuvant chemotherapy followed by radical hysterectomyEriko Takatori, Tadahiro Shoji, Hideo Omi, et al.
Pageof 9